Collin Jacobs

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Metastasis: from dissemination to organ-specific colonization

Dendritic cells in cancer immunology and immunotherapy

Platelet pharmacogenomics

Cancer to bone: a fatal attraction

Cancer Metastasis: Building a Framework

Dissemination and growth of cancer cells in metastatic sites

TLR based therapeutics

Archaeosome Adjuvant Overcomes Tolerance to Tumor‐Associated Melanoma Antigens Inducing Protective CD8⁺ T Cell Responses

Cancer immunotherapy via dendritic cells

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

Tumor-Associated Macrophages: From Mechanisms to Therapy

A multigenic program mediating breast cancer metastasis to bone

C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer

Vaccine adjuvants – understanding molecular mechanisms to improve vaccines

Emerging Biological Principles of Metastasis

Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

Tumour-associated macrophages as treatment targets in oncology

Metastasis to bone: causes, consequences and therapeutic opportunities

Microenvironmental regulation of metastasis

Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase

Tumor metastasis: mechanistic insights and clinical challenges

Mechanisms of Bone Metastasis

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases

Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*†

CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γResponses

A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins

Osteoinduction, osteoconduction and osseointegration

No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors.

Pitfalls in the use of transfected overexpression systems to study membrane proteins function: the case of TSH receptor and PRA1

An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma

Human amniotic tumor that induces new bone formation in vivo produces growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor.